Chief Executive Officer and Director since February 2020 and President of the Company from December 2016 to October 2025. Chief Operating Officer of the Company from February 2017 to February 2020. Co-President of the Company from October 2015 to December 2016. Executive Vice President and Chief Operating Officer of the Company from March 2010 to September 2015. Executive Vice President Operations and Technology of the Company from December 2005 to March 2010. Senior Vice President and Chief Information Officer of the Company from May 2003 to December 2005. Officer and/or director of certain subsidiaries of the Company, including certain of the specialist investment managers acquired through the Legg Mason transaction. Director or trustee of certain funds registered as investment companies managed or advised by subsidiaries of the Company. Director of Thermo Fisher Scientific Inc., a science service company since July 2023. Ms. Johnson brings significant experience leading and working with all parts of our business, as well as extensive knowledge of the global investment management industry. Over her 35-year tenure with the Company, Ms. Johnson has held leadership roles in all major divisions of the business, including investment management, global distribution, customer service, fund administration, global technology, and the Company s high-net-worth business. This extensive hands-on experience provides her with in-depth knowledge of the Company s operations. She has been a key driver of many key acquisitions, including the acquisitions of Legg Mason in 2020 and Putnam Investments in 2024, as well as the expansion of the Company s alternative investment capabilities through the acquisitions of Lexington Partners in April 2022 and Alcentra in November 2022. Under Ms. Johnson s leadership, the Company continues to invest strategically in areas designed to deliver strong client results, including financial technology and investment data science.